Paul Humphries

Customer Advisor at Collaborative Drug Discovery

Dr. Humphries is Alliance Director of Stanford Innovative Medicines Accelerator. He was previously Chief Scientific Officer at Reset Therapeutics. Dr, and before that a Senior Principal Scientist at Pfizer for 8 years working in the area of Metabolic Diseases. He received his B.Sc. & Ph.D. from the University of Sheffield in the UK and performed postdoctoral research at Florida State University.

While at Pfizer, Dr. Humphries worked on programs resulting in seven IND submissions across four late-stage projects and was responsible for numerous go/no go decisions on early-stage projects. He authored more than 25 scientific articles and patents on a wide range of topics/drug targets and received the Pfizer Global R&D Achievement Award in 2005.